Venture capitalists re-emerge for Movetis IPO
Health / Medicine Related News
A two-year drought of initial public offerings by venture capital-backed companies in Europe will be broken when the gastrointestinal drugs group floats on Euronext in Brussels
Source: FT.com - Pharmaceuticals